Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-004010

Options or other derivatives

  • Director acquired 16,835 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Bauer Jake Director 2024-02-13 Grant or award · Stock Option (right to buy) +16,835 16,835 D: show line 1 in the form
Loading xslF345X05/form4-02162024_010212.xml…